Findings could lead to universal therapies for alcohol, tobacco, cannabis, opioid addictions
Multiple substance use disorders may share inherited genetic signature
Category: Clocks & Sleep
Discovery of T cells’ role in Alzheimer’s, related diseases, suggests new treatment strategy
Findings, in mice, open up drug development possibilities for brain diseases linked to tau protein
Miller receives Rainwater Prize for Brain Research
Honored for work developing new kind of therapy for neurodegenerative diseases
Challenges With Tailoring Diets in Multiple Sclerosis: Laura Piccio, MD, PhD
The neurologist and physician scientist at Washington University in St. Louis provided insight on the general dieting strategies patients with multiple sclerosis should take as more information becomes available. [WATCH TIME: 6 minutes]
Gut bacteria affect brain health, mouse study shows
Findings suggest new approach to treating Alzheimer’s, other neurodegenerative diseases
Future Thoughts and Reason for Excitement in ALS: Timothy Miller, MD, PhD
“These trials don’t go without huge input and commitment from the participants and of course, their caregivers, and the clinical trial sites. I have the privilege of speaking to you about the trial as the lead author of this paper, but this is a team effort and includes a large group of people from multiple […]
Study yields clues to why Alzheimer’s disease damages certain parts of the brain
Findings could help explain rare symptoms such as problems with language, vision
Herzog installed as Viktor Hamburger Distinguished Professor
Installation talk, titled “For Whom the Bells Toll: Networked Circadian Clocks and Clock Watchers”
Rejuvenated immune cells can improve clearance of toxic waste from brain
Findings in mice suggest new therapeutic approach to Alzheimer’s, other age-related diseases
Understanding, treating pain, reducing opioid use, aim of $11.7 million grant
Funding from NIH HEAL Initiative
Cellular housekeeping process implicated in fatal neurological disorder
Neurons made from Huntington’s disease patients’ skin cells shed light on cognitive decline
Investigational drug for genetic form of ALS improves disease’s molecular signs
Extended use of tofersen may help stabilize muscle strength, control
Problems persist for kids exposed to cannabis in the womb
Research finds kids with prenatal exposure show more signs of psychopathology
How deep sleep keeps our brains intact
WashU was first to reveal the intricate link between fragmented sleep and dementia
Risky driving behaviors increase as common sleep disorder worsens
Diagnosing, treating sleep apnea may make driving safer for older adults
Kerschensteiner to research visual pathways
Five-year $2 million grant from NIH
Hit the sleep ‘sweet spot’ to keep brain sharp
Too little and too much sleep linked to cognitive decline
Emotional aspects of chronic pain isolated in brain circuitry
Animal study could help ID new treatment targets for negative emotions linked to pain
Creed honored for research involving mood, chronic pain, substance use
Neuroscientist receives award from Brain & Behavior Research Foundation
$35 million to support study of sleep disorder linked to neurodegeneration
International team seeks hidden signs of brain damage in REM behavior disorder
‘Fight or flight’ – unless internal clocks are disrupted, study in mice shows
For humans and animals, many aspects of normal behavior and physiology rely on the proper functioning of the body’s circadian clocks.
Time until dementia symptoms appear can be estimated via brain scan
Alzheimer’s dementia predicted by brain amyloid levels, age
Cannabis use disorder: another COVID risk factor
Research indicates problematic marijuana use is correlated with poorer COVID-19 outcomes
Creed and Other Outstanding Mental Health Researchers Honored by the Brain & Behavior Research Foundation
The Brain & Behavior Research Foundation (BBRF) has announced the winners of its 2021 Klerman and Freedman Prizes, which recognize exceptional clinical and basic research in mental illness. The prizes are awarded annually to honor the work of outstanding scientists who have been supported by the Foundation’s Young Investigator Grants Program. “The Klerman and Freedman prizes […]
Protein linked to heart health, disease a potential therapeutic target for dementia
Brain protein reduces Alzheimer’s-like brain damage in mice
Studies reveal skull as unexpected source of brain immunity
Immune cells from skull bone marrow guard the brain, spinal cord
Burris Receives $150,000 Washington University School of Medicine Grant for Autophagy Research
Tom Burris, Ph.D., FAAAS, FAHA, Alumni Chair in Pharmaceutical Education and vice president for research at University of Health Sciences and Pharmacy in St. Louis, has received a $150,000 grant from the Washington University School of Medicine in St. Louis’ Philip and Sima Needleman Center for Autophagy Therapeutics and Research to support research related to […]
Draining brain’s debris enhances Alzheimer’s therapies in mice
Impaired drainage also may play a role in Alzheimer’s in people
Anti-aging compound that improves metabolic health in mice improves muscle glucose metabolism in people
Further studies underway to determine extent of clinical benefits
Chemo for glioblastoma may work better in morning than evening
Study indicates timing of chemotherapy could improve treatment for deadly brain cancer